Today: 10 June 2026
Lam Research stock rises after-hours as Susquehanna lifts target to $250
13 January 2026
1 min read

Lam Research stock rises after-hours as Susquehanna lifts target to $250

New York, January 12, 2026, 17:54 EST — After hours

Lam Research Corp (LRCX) shares climbed 0.9% to $220.40 in after-hours trading Monday, after fluctuating between $213.90 and $222.57 during the session. Susquehanna analyst Mehdi Hosseini raised his price target on the chip-equipment maker from $200 to $250, maintaining a Positive rating. He noted that wafer-fab equipment trends “remain strong.” TipRanks

The note matters because investors are weighing if the next wave of chip spending reflects genuine demand or merely a catch-up cycle. Lam has a front-row seat, right by the cash register, when customers ramp up new capacity.

That’s the current narrative for toolmakers: how robust factory budgets remain and for how long. Even a slight sign that orders are slowing can send these stocks tumbling quickly.

Bernstein bumped its price target on Lam from $175 to $225, keeping an Outperform rating intact. The firm pointed to upbeat 2025 guidance and suggested a NAND upgrade cycle—linked to flash memory in data storage—“may be starting.”

Lam’s jump coincided with solid gains in semiconductor equipment stocks during regular trading. KLA and Applied Materials each ended roughly 2% higher, while the S&P 500 nudged up 0.16%.

The iShares Semiconductor ETF (SOXX) gained roughly 0.5% during the session.

Lam announced on Jan. 7 that its December-quarter earnings call and webcast are set for Jan. 28 at 5 p.m. ET.

Wafer-fab equipment, known as WFE, refers to the machines that manufacture chips. Investment usually spikes during major expansions in memory and logic production, then tapers off once inventories become excessive.

But those optimistic targets rely on customers continuing to write checks. Any slowdown in memory demand, postponed fab projects, or budget reallocations could quickly derail Lam’s forecasts.

In the upcoming session, traders will be eyeing any follow-up moves from analysts and clues from peers about spending discipline.

Lam’s next major event comes Jan. 28, when it reports earnings and shares its outlook for the WFE cycle through 2026.

Stock Market Today

  • Dynatrace (DT) Shares Show 33% Discount Based on Cash Flow Valuation
    June 10, 2026, 5:31 PM EDT. Dynatrace (DT) share price fell 9.3% last week, trading around $40.77, down 3.7% year to date. A discounted cash flow (DCF) analysis values the stock at $61.13, suggesting a 33.3% undervaluation. The model projects free cash flow rising to $1.04 billion by 2031. Despite mixed sentiment in software and cloud sectors, this cash flow based approach indicates potential value. Dynatrace scored 2 out of 6 on Simply Wall St's valuation framework, reflecting investor caution amid growth and revenue concerns. This highlights reassessment of pricing for cloud software stocks amid shifting market perspectives on growth sustainability.

Latest articles

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Freshworks Stock Steady at $9.39 Ahead of AI Test

Freshworks Stock Steady at $9.39 Ahead of AI Test

10 June 2026
Freshworks traded flat near $9.39 on volume more than double average as investors weighed its AI-driven restructuring and Freshservice focus; with Q2 restructuring costs looming, the stock faces a key test to prove AI shifts can boost margins without hurting growth, while net dollar retention dipped to 106% and large-customer ARR rose 29%.
ERock Falls in NYSE Debut, AI Power Firm Starts Trading Below IPO Price

ERock Falls in NYSE Debut, AI Power Firm Starts Trading Below IPO Price

10 June 2026
ERock plunged 12.37% below its $21.50 IPO price on debut as investors questioned whether its $1.28 billion AI data-center power-system backlog—$1.1 billion tied to AI projects—will convert to revenue, despite surging demand and a major Meta contract; risks flagged include customer cancellations and execution challenges, with the company posting a $17.2 million quarterly loss.
Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal
Previous Story

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop